As drugmakers navigate an increasingly complex terrain of scientific and digital influence, the ability to accurately ...

FDA warns major pharmaceutical companies to improve transparency in drug advertising, addressing misleading claims and ...

Eli Lilly's Orforglipron shows superior results in glycemic control and weight loss compared to oral semaglutide in recent ...

VarmX announced its partnership with CSL, supporting the development of its lead asset VMX-C001, along with entering into an ...

He has held appointments as Visiting Professor or Distinguished Lecturer at Princeton University, Vanderbilt University, the ...

Outlining the key touchpoints for embracing change and opportunity in the “messy, tough—and fun” R&D-to-commercial transition ...

In today’s Pharmaceutical Executive Daily, we cover AbbVie’s stock jump following a Rinvoq litigation settlement, new ...

Ryan Quigley, CEO of Inizio, discusses how his experience as Chief Operating Officer shaped his journey to CEO.

AllRock Bio secures $50 million to advance Roc-101, a promising treatment for pulmonary hypertension, aiming to transform patient care.